Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Prognosis
9 results:

  • 1. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
    Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel prognostic model for patients with colon adenocarcinoma.
    Yin C; Wang W; Cao W; Chen Y; Sun X; He K
    Front Endocrinol (Lausanne); 2023; 14():1133554. PubMed ID: 36923226
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TRAIL signaling promotes entosis in colorectal cancer.
    Bozkurt E; Düssmann H; Salvucci M; Cavanagh BL; Van Schaeybroeck S; Longley DB; Martin SJ; Prehn JHM
    J Cell Biol; 2021 Nov; 220(11):. PubMed ID: 34546352
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
    Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
    [No Abstract]    [Full Text] [Related]  

  • 6. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
    Morita R; Hirohashi Y; Torigoe T; Ito-Inoda S; Takahashi A; Mariya T; Asanuma H; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Kutomi G; Mizuguchi T; Terui T; Ishitani K; Hashino S; Kondo T; Minagawa N; Takahashi N; Taketomi A; Todo S; Asaka M; Sato N
    Clin Cancer Res; 2016 Jul; 22(13):3298-309. PubMed ID: 26861454
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria.
    Turner N; Wong HL; Templeton A; Tripathy S; Whiti Rogers T; Croxford M; Jones I; Sinnathamby M; Desai J; Tie J; Bae S; Christie M; Gibbs P; Tran B
    Int J Cancer; 2016 Feb; 138(3):671-8. PubMed ID: 26270488
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of acute-phase proteins (APP) in circulating immune complexes (cic) in esophageal cancer patients' sera.
    Croce MV; Segal-Eiras A
    Cancer Invest; 1996; 14(5):421-6. PubMed ID: 8816857
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.